Latest News

  • Indicative Net Profit for 2012 Increased by 17%

    Monday, February 4, 2013

    Jakarta, February 4, 2013 – PT Kalbe Farma Tbk and its subsidiaries (“Kalbe” or “the Company”) today announced the Company’s indicative performance (unaudited) for the year 2012. Indicative consolidated net profit reached Rp 1.73 Trillion for year 2012, an increase of approximately 17% compared to Rp 1.48 Trillion last year, mostly driven by strong top line growth and higher efficiency. Indicative earnings per share increased by approximately 17%, to Rp 36.9 per share from Rp 31.6 per share.

  • Kalbe’s Net Profit in First 9 Months of 2012 Surged by 16.7%

    Wednesday, October 31, 2012

    Jakarta, October 31, 2012 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced a consolidated (unaudited) net profit of Rp 1,243 Billion for the first 9 months of 2012, an increase of 16.7% compared to the same period last year of Rp 1,065 Billion, mostly driven by strong sales growth. Earnings per share increased by 16.7% from Rp 114 per share to Rp 133 per share.

  • Kalbe Received Frost & Sullivan Asia Pacific 2012 Award

    Fastest Growing Home Grown Company in Oncology Care

    Tuesday, October 23, 2012

    Jakarta, 23 October 2012 – PT Kalbe Farma Tbk (Kalbe) through one of its subsidiaries, Innogene Kalbiotech, received an award for the category Fastest Growing Home Grown Company for Oncology Care, from Frost & Sullivan Asia Pacific 2012.

  • Kalbe Family Rewards Card

    Embracing Customers through One Kalbe Family Programme

    Wednesday, August 8, 2012

    Jakarta, 8th August 2012 – PT Kalbe Farma Tbk (Kalbe) launched the Kalbe Family Rewards Card today, a program to embrace all customers through one Kalbe family. By obtaining and using Kalbe Family Rewards Card, consumers can enjoy special benefits such as point rewards with every purchase of Kalbe products in Kalbe e-store and Kalbe Home Delivery, or special discounts, free products and other offers in Kalbe’s partner merchants.

  • Kalbe’s Net Profit Surged by 19.6% in First Half 2012

    Tuesday, July 31, 2012

    Jakarta, July 31, 2012 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced a consolidated (unaudited) net profit of Rp 807 Billion for the first semester 2012, an increase of 19.6% compared to the same period last year of Rp 675 Billion, mostly driven by strong sales growth. Earnings per share increased by 19.6% from Rp 72 per share to Rp 86 per share.

RSS
First3738394041Last